Longitudinal changes of trabecular bone score after estrogen deprivation: effect of menopause and aromatase inhibition

Journal of Endocrinological Investigation - Tập 37 - Trang 871-874 - 2014
M. Pedrazzoni1, A. Casola1, I. Verzicco1, B. Abbate1, R. Vescovini1, P. Sansoni1
1Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy

Tóm tắt

To examine the effects of the menopausal transition and treatment with aromatase inhibitors (AI) on trabecular bone score (TBS, a newly proposed index of bone architecture derived from DXA vertebral scans) and vertebral bone mineral density (BMD). Retrospective cohort study on 29 women who became postmenopausal during a mean follow-up of 2.9 years (MP group) and 34 women treated with AI during a mean follow-up of 2.1 years (AI group). BMD was measured by DXA and TBS with a specific software. TBS decreased after menopause, but the change was significantly lower than that of the lumbar BMD (−4.6 vs. −6.8 %; mean difference: 2.2 %; p = 0.016). An even larger difference was observed in the AI group (−2.1 vs. −5.9 %; mean difference: 3.8 %; p = 0.002). The decrease of TBS induced by menopause or treatment with AI is significantly lower than that of lumbar BMD.

Tài liệu tham khảo

Bousson V, Bergot C, Sutter B et al (2012) Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects. Osteoporos Int 23:1489–1501. doi:10.1007/s00198-011-1824-6 Silva BC, Leslie WD, Resch H et al (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 29:518–530. doi:10.1002/jbmr.2176 Finkelstein JS, Brockwell SE, Mehta V et al (2008) Bone mineral density changes during the menopause transition in a multiethnic cohort of women. JCEM 93:861–868. doi:10.1210/jc.2007-1876 Lustberg MB, Reinbolt RE, Shapiro CL (2012) Bone health in adult cancer survivorship. J Clin Oncol 30:3665–3674. doi:10.1200/JCO.2012.42.2097 Cauley JA, Danielson ME, Greendale GA (2013) Skeletal changes across menopause. In: Marcus R, Feldman D, Dempster DW et al (eds) Osteoporosis, 4th edn. Academic Press, Waltham, pp 745–756 Simonelli C, Leib E, Mossman N et al (2014) Creation of an age-adjusted, dual-energy X-ray absorptiometry-derived trabecular bone score curve for the lumbar spine in non-hispanic US white women. J Clin Densitom. doi:10.1016/j.jocd.2013.09.002 Dufour R, Winzenrieth R, Heraud A et al (2013) Generation and validation of a normative, age-specific reference curve for lumbar spine trabecular bone score (TBS) in French women. Osteoporos Int 24:2837–2846. doi:10.1007/s00198-013-2384-8 Kalder M, Hans D, Kyvernitakis I et al (2014) Effects of exemestane and tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer. J Clin Densitom 17:66–71. doi:10.1016/j.jocd.2013.03.003 Cheung AM, Tile L, Cardew S et al (2012) Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. Lancet Oncol 13:275–284. doi:10.1016/S1470-2045(11)70389-8 Cauley JA (2012) Bone loss associated with prevention of breast cancer. Lancet Oncol 13:221–222. doi:10.1016/S1470-2045(12)70030-X